HikariQ Health Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $498K

  • Investors
  • 9

HikariQ Health General Information

Description

Developer of antibody engineering technology designed for immunological testing and antibody-based drug development. The company develops immunoassay methods based on antibody modification technology and applies the same technological approach to antibody drug development, combining the use of engineered antibodies for immunological measurement with research into antibody-based medicines and their development, enabling researchers and pharmaceutical developers to pursue antibody-based testing methods and therapeutic research.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Shiba NA Building
  • 3-6-10 Shiba, Minato-ku
  • Tokyo, 105-0014
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5th Floor, Shiba NA Building
  • 3-6-10 Shiba, Minato-ku
  • Tokyo, 105-0014
  • Japan

HikariQ Health Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HikariQ Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 27-Jan-2023 $498K Completed Generating Revenue
6. Accelerator/Incubator 26-Jan-2023 Completed Generating Revenue
5. Accelerator/Incubator 19-Aug-2022 Completed Generating Revenue
4. Accelerator/Incubator 05-Aug-2022 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Corporate 12-Apr-2022 Completed Startup
1. University Spin-Out 10-Aug-2021 Completed Startup
To view HikariQ Health’s complete valuation and funding history, request access »

HikariQ Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HikariQ Health Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Business Creation Capital Venture Capital Minority
Coral Capital. Venture Capital Minority
NBC Angel Fund No. 2 Angel Group Minority
UT Founder's Association Corporation Minority
The University of Tokyo Founder's Association Support Fund Accelerator/Incubator Minority
You’re viewing 5 of 9 investors. Get the full list »

HikariQ Health FAQs

  • When was HikariQ Health founded?

    HikariQ Health was founded in 2021.

  • Where is HikariQ Health headquartered?

    HikariQ Health is headquartered in Tokyo, Japan.

  • What is the size of HikariQ Health?

    HikariQ Health has 10 total employees.

  • What industry is HikariQ Health in?

    HikariQ Health’s primary industry is Drug Discovery.

  • Is HikariQ Health a private or public company?

    HikariQ Health is a Private company.

  • What is the current valuation of HikariQ Health?

    The current valuation of HikariQ Health is .

  • What is HikariQ Health’s current revenue?

    The current revenue for HikariQ Health is .

  • How much funding has HikariQ Health raised over time?

    HikariQ Health has raised $498K.

  • Who are HikariQ Health’s investors?

    Business Creation Capital, Coral Capital., NBC Angel Fund No. 2, UT Founder's Association, and The University of Tokyo Founder's Association Support Fund are 5 of 9 investors who have invested in HikariQ Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process